The Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin

Area of Science:

• Pharmacology
• Chronobiology
• Metabolic Diseases

Background:

• Metformin is a cornerstone therapy for type 2 diabetes, but its efficacy varies.
• Understanding metformin's pharmacokinetics and pharmacodynamics is crucial due to potential side effects like lactic acidosis.
• Existing knowledge gaps hinder optimal therapeutic use of this common medication.

Purpose of the Study:

• To investigate the influence of time of day on metformin's effects on blood glucose and lactate levels.
• To explore the impact of circadian rhythms on metformin-induced AMP-activated protein kinase (AMPK) activation in the liver.
• To examine the role of the Bmal1 gene in mediating metformin's time-dependent responses.

Main Methods:

• Administration of metformin to healthy mice at different times of day.
• Measurement of acute blood glucose reduction and blood lactate levels.
• Assessment of metformin transport into hepatocytes and liver AMPK activation kinetics.
• Analysis of metformin response in mice with liver-specific Bmal1 gene ablation.

Main Results:

• Significant time-of-day effects were observed on metformin's glucose-lowering action and blood lactate levels in mice.
• Metformin transport into liver cells was not affected by circadian time.
• The kinetics of metformin-induced liver AMPK activation showed significant circadian variation.
• Liver-specific Bmal1 knockout altered metformin's effects but did not eliminate time-of-day differences.

Conclusions:

• Circadian rhythms play a complex role in modulating the biological responses to metformin.
• The timing of metformin administration may influence its therapeutic outcomes and safety profile.
• Further research into chronopharmacology could optimize metformin treatment strategies for type 2 diabetes.